Diplomat Announces Executive Promotion for Jennifer Hagerman
FLINT, Mich. – April 26, 2016 – The nation’s largest independent specialty pharmacy has promoted Jennifer Hagerman, Pharm D., to Vice President of Education and Quality.
Diplomat Pharmacy, Inc. (NYSE: DPLO) is pleased to announce the promotion of Jennifer Hagerman, Pharm D., to Vice President of Education and Quality.
In her growing role at Diplomat, Hagerman will continue to lead and oversee Diplomat University, an innovative division of the company that delivers custom education and training to Diplomat employees and external professionals on topics unique to the specialty pharmacy industry. Diplomat University also houses the quality assurance department, which focuses on programs that promote quality and patient safety, as well as our application for service excellence in accreditations and certifications by a number of third-party agencies committed to industry best practices. These include ACHC, ASHP, CPPA, The Joint Commission, URAC, VAWD and VIPPS.
To learn more about Diplomat’s executive team, click here.
“We are extremely proud to recognize Jennifer’s contribution to our collective success with this promotion,” said Gary Rice, Senior Vice President of Clinical Services, Education and Human Resources at Diplomat. “Jennifer has demonstrated a commitment to improving education and quality measures that allow us to meet the needs of our patients, our partners, and our employees. She has built a strong and capable team to help Diplomat navigate a complex landscape and will continue to be a leading example as she brings significant experience in the space and continues to be a great asset to our team.”
Prior to joining Diplomat, Hagerman served as an associate professor at Ferris State University College of Pharmacy with a practice site at Hurley Medical Center. In addition, she served for three years as adjunct faculty in the Department of Nursing at the University of Michigan–Flint.
Hagerman is very active in the pharmacy profession. She has served as a member of the Michigan Pharmacists Association (MPA) Executive Board since 2011, including serving as president in 2015 and chairman in 2016. She has also served on the board of the Michigan Pharmacy Foundation. In 2009, Hagerman earned the MPA Distinguished New Pharmacy Practitioner Award.
Hagerman received her Doctor of Pharmacy degree from Ferris State University College of Pharmacy in 2003. After gradation, she completed an ASHP-accredited PGY-1 pharmacy residency at Borgess Medical Center in Kalamazoo, Michigan.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended December 31, 2015 and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Kali Lucas, Public Relations Coordinator
810.768.9580 | email@example.com
@PharmacDailyRT @PharmacDaily: @DiplomatRx to distribute Puma Biotechnology’s new cancer drug $DPLO https://t.co/gl0v6WURVV5 days ago
@DiplomatRxNerlynx (neratinib) tablets for HER2+ Breast Cancer in the Extended Adjuvant Setting https://t.co/vi3ACWhbfe5 days ago
@AJPB_JournalRT @AJPB_Journal: Be sure to check out our Insights page featuring videos of Cheryl Allen from @DiplomatRx discussing #RA https://t.co/qxZc…2 weeks ago
@DiplomatRxWe're with @340BCoalition this week in Washington D.C.! Come say hello.3 weeks ago
@SpecialtyPTimesRT @SpecialtyPTimes: Rheumatoid Arthritis Treatment Guidelines https://t.co/sEhe74UozC #rheumatoidarthritis @DiplomatRx3 weeks ago